These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 22836195

  • 1. Biologic treatments in Sjögren's syndrome.
    Bowman S, Barone F.
    Presse Med; 2012 Sep; 41(9 Pt 2):e495-509. PubMed ID: 22836195
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The future of B cell-targeted therapies in Sjögren's syndrome.
    Cornec D, Saraux A, Devauchelle-Pensec V, Clodic C, Pers JO.
    Immunotherapy; 2013 Jun; 5(6):639-46. PubMed ID: 23725286
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?
    Meiners PM, Vissink A, Kallenberg CG, Kroese FG, Bootsma H.
    Expert Opin Biol Ther; 2011 Oct; 11(10):1381-94. PubMed ID: 21819314
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rituximab therapy in primary Sjögren's syndrome.
    Alcântara C, Gomes MJ, Ferreira C.
    Ann N Y Acad Sci; 2009 Sep; 1173():701-5. PubMed ID: 19758218
    [Abstract] [Full Text] [Related]

  • 11. B-cell populations and sub-populations in Sjögren's syndrome.
    Hamza N, Bos NA, Kallenberg CG.
    Presse Med; 2012 Sep; 41(9 Pt 2):e475-83. PubMed ID: 22841377
    [Abstract] [Full Text] [Related]

  • 12. Primary Sjogren's syndrome: current and prospective therapies.
    Thanou-Stavraki A, James JA.
    Semin Arthritis Rheum; 2008 Apr; 37(5):273-92. PubMed ID: 17714766
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Present and novel biologic drugs in primary Sjögren's syndrome.
    Fasano S, Isenberg DA.
    Clin Exp Rheumatol; 2019 Apr; 37 Suppl 118(3):167-174. PubMed ID: 31025931
    [Abstract] [Full Text] [Related]

  • 15. Anti-B cell antibody therapies for inflammatory rheumatic diseases.
    Faurschou M, Jayne DR.
    Annu Rev Med; 2014 Apr; 65():263-78. PubMed ID: 24160940
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment.
    Both T, Dalm VA, van Hagen PM, van Daele PL.
    Int J Med Sci; 2017 Apr; 14(3):191-200. PubMed ID: 28367079
    [Abstract] [Full Text] [Related]

  • 20. Biological therapies in primary Sjögren's syndrome.
    Ng WF, Bowman SJ.
    Expert Opin Biol Ther; 2011 Jul; 11(7):921-36. PubMed ID: 21457124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.